Isolation of Enteric Glial Cells from the Submucosa and Lamina Propria of the Adult Mouse
August 15th, 2018
13.7K views
Here, we describe the isolation of enteric-glial cells from the intestinal-submucosa using sequential EDTA incubations to chelate divalent cations and then incubation in non-enzymatic cell recovery solution. Plating the resultant cell suspension on poly-D-lysine and laminin results in a highly enriched culture of submucosal glial cells for functional analysis.
Overview
This article describes a rapid, non-enzymatic method for isolating enteric-glial cells from the intestinal submucosa. The technique utilizes sequential EDTA incubations to chelate divalent cations, followed by incubation in a non-enzymatic cell recovery solution, resulting in a highly enriched culture for functional analysis.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Enteric Nervous System
Background
- Enteric-glial cells play a crucial role in the enteric nervous system.
- Isolation of these cells is essential for studying their function.
- Traditional methods may involve enzymatic treatments, which can be time-consuming.
- This study presents a non-enzymatic approach to enhance efficiency.
Purpose of Study
- To develop a rapid method for isolating enteric-glial cells.
- To facilitate functional analysis of these cells.
- To improve understanding of the enteric nervous system's role in gut physiology.
Methods Used
- Sequential EDTA incubations to chelate divalent cations.
- Non-enzymatic cell recovery solution for cell isolation.
- Plating on poly-D-lysine and laminin for cell culture.
- Dissection techniques to obtain intestinal samples.
Main Results
- Successful isolation of enteric-glial cells from the intestinal submucosa.
- High enrichment of submucosal glial cells for analysis.
- Demonstrated efficiency of the non-enzymatic method.
- Potential for further research into the enteric nervous system.
Conclusions
- The non-enzymatic method is effective for isolating enteric-glial cells.
- This technique can advance research in neuroscience.
- Further studies can explore the functional roles of these cells.
Frequently Asked Questions
What are enteric-glial cells?
Enteric-glial cells are supportive cells in the enteric nervous system that play a role in gut function.
Why is a non-enzymatic method preferred?
Non-enzymatic methods are faster and may preserve cell functionality better than enzymatic methods.
What is the significance of isolating these cells?
Isolating enteric-glial cells allows researchers to study their specific functions and roles in gut health.
How does this method compare to traditional techniques?
This method is quicker and avoids the potential damage caused by enzymatic treatments.
What applications can arise from this research?
The findings can lead to better understanding of gut disorders and the enteric nervous system's role in health.
Can this method be applied to other cell types?
While this method is tailored for enteric-glial cells, similar techniques may be adapted for other cell types.
Executive Industry Relevance
Isolation of enteric glial cells from submucosal and lamina propria layers enables mechanistic de-risking of gut-brain axis targets in preclinical models. This non-enzymatic method provides a disease-relevant system for evaluating glial modulation in intestinal barrier function and neuroimmune interactions. The approach supports target validation by yielding purified glial populations for functional assays in early discovery workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of glial-specific pathways in gut homeostasis and epithelial barrier integrity.
- Operational Value: Provides a rapid, non-enzymatic isolation protocol compatible with downstream functional readouts.
Screening & Assay Development
- Scientific Value: Generates highly enriched (>95% GFAP+) glial cultures for consistent compound screening in glial-mediated pathways.
- Operational Value: Standardized dissociation yields reproducible cell preparations suitable for assay miniaturization.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant modeling of enteric glial contributions to mucosal immunity and microbiota interactions.
- Operational Value: Enables longitudinal culture (≥5 days) for time-dependent phenotypic screening and target engagement studies.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target hypothesis testing to preclinical validation, providing glial-enriched inputs for mechanistic de-risking before lead optimization.
- Discovery Biology: Facilitates target validation by isolating glial cells from specific intestinal compartments for pathway-specific hypothesis testing.
- Screening: Delivers standardized glial suspensions with defined purity for assay development and compound profiling.
- Analytics: Enables quantitative readouts via GFAP expression, calcium flux, and biomarker detection for condition comparison.
- Translational Research: Connects glial isolation to preclinical continuity through culture stability and functional assay compatibility.
- Enterprise Reuse: Establishes a reusable isolation platform for multiple glial-targeted programs across neuroscience and gastroenterology portfolios.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in glial target modulation through compartment-specific cell isolation.
- Operational Value: Reproducible, scalable dissociation without enzymatic variability.
- Strategic Value: Reduced biological de-risking timelines via direct access to submucosal glial populations.
- Portfolio Impact: Informed go/no-go decisions based on glial-specific functional data in disease-relevant systems.
Implementation Considerations
- Requires expertise in intestinal dissection and glial marker identification.
- Dependent on access to EDTA, cell recovery solution, and poly-D-lysine/laminin coating infrastructure.
- Necessitates standardization across teams for consistent tissue preparation and enrichment metrics.
- Adaptation considerations include species-specific tissue thickness and submucosal glial density.
- Practical limitations include variable epithelial stripping efficiency affecting glial yield prior to culture enrichment.
Biopharma FAQs
Why does EDTA incubation depth matter for glial yield?
Sequential EDTA incubations strip epithelial mucosa to expose submucosal glial cells; insufficient incubation leaves epithelial contamination reducing glial purity before culture enrichment.
How does non-enzymatic dissociation support target validation assays?
Gentle dissociation preserves glial surface markers and functionality, enabling reliable detection of GFAP, S100B, and p75NTR in downstream functional analysis without protease-induced artifacts.
What quantitative measurement confirms glial enrichment post-culture?
Flow cytometry or immunocytochemistry for GFAP+ cells quantifies enrichment, with the protocol achieving >95% purity after 3 days in GDNF-containing media, confirming assay-ready glial populations.
Why replicate isolation across intestinal segments for screening consistency?
Replication ensures standardized glial yield and purity across wells, minimizing variability in compound screening data and supporting reproducible target engagement measurements.
What statistical analysis is required to compare glial responses across conditions?
Comparative analysis of glial marker expression, process extension, or calcium flux requires normalized quantification and appropriate statistical testing to determine significant differences between experimental and control conditions.
